In 2014, a committee of clinicians and nuclear medicine experts issued the recommendations for lymphoma staging and restaging based on the use of positron emission tomography/computed tomography (PET/CT). These recommendations were immediately adopted in the Western countries and have become part of the routine clinical use. In contrast, the adoption of these recommendations has been gradual in many non-Western countries, and around the world in general, depending on the availability of dedicated and skilled technicians and doctors, and on the accessibility to economic resources in the healthcare system for the reimbursement of the cost of the procedure. This chapter presents a portrait of the adoption and accessibility of PET/CT in Uruguay, Argentina, Ukraine, and Saudi Arabia. The chapter concludes with a section on the reproducibility of SUV-related indexes for PET/CT reporting in lymphoma.
Copyright: The Authors.; The author confirms that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced.